How a gene change can boost movement and recovery
Mechanisms of Motor Superperformance
Researchers are looking at a specific gene change that helps mice move better to learn ways to improve movement and recovery for people with motor problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11193829 on NIH RePORTER |
What this research studies
From a patient point of view, the team is using thousands of mice to find rare genetic changes that make movement stronger, then reproducing those changes with CRISPR to study how they work. They screen animals on motor tests like the rotarod and examine whether the same changes help recovery after brain injury such as stroke. The work focuses on a gene called Rif1, which was unexpected but seems to boost motor performance without harming other behaviors or lifespan. Findings in mice may point toward molecular targets that could be tested later for therapies to help people with weakness or movement disorders.
Who could benefit from this research
Good fit: People with motor impairments such as stroke survivors, spinal cord injury patients, or those with neuromuscular diseases (for example Duchenne muscular dystrophy) are the groups most likely to benefit from therapies inspired by this work.
Not a fit: Patients with conditions that do not affect movement (purely cognitive disorders) or those looking for an immediate treatment option are unlikely to benefit directly from this mouse-focused research.
Why it matters
Potential benefit: If successful, this work could reveal new gene or molecular targets to improve mobility and speed recovery after stroke or other motor disorders.
How similar studies have performed: Related animal research has linked DNA repair and gene-regulatory mechanisms to nerve function and recovery, but using a Rif1 mutation to boost motor abilities is a novel and largely untested approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Pascual, Juan M. — Weill Medical Coll of Cornell Univ
- Study coordinator: Pascual, Juan M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.